Related Experiment Videos
Prognostic factors in chronic lymphocytic leukemia
Czechoslovak Medicine
|January 1, 1984
Summary
Prognostic markers for chronic lymphocytic leukemia (CLL) were evaluated. While total tumor mass (TTM) scoring at diagnosis was not prognostic, its doubling time (DT TTM) showed potential importance for predicting CLL outcomes.
Area of Science:
- Hematology
- Oncology
- Medical Statistics
Background:
- Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy.
- Accurate prognostic markers are crucial for guiding CLL treatment strategies.
- Existing prognostic models require further validation and refinement.
Purpose of the Study:
- To evaluate the prognostic value of qualitative and quantitative indices in chronic lymphocytic leukemia (CLL).
- To assess the Jaksic and Vitale prognostic parameter, focusing on total tumor mass (TTM).
- To investigate the significance of TTM doubling time (DT TTM) as a prognostic indicator in CLL.
Main Methods:
- Retrospective analysis of literary data for 117 CLL patients.
- Evaluation of the Jaksic and Vitale prognostic parameter (TTM).
- Calculation and assessment of the doubling time of total tumor mass (DT TTM).
Main Results:
- The prognostic value of total tumor mass (TTM) scoring at the time of CLL diagnosis was not confirmed in this patient group.
- The doubling time of total tumor mass (DT TTM) emerged as a potentially significant prognostic factor.
- Further research is needed to establish reliable prognostic criteria.
Conclusions:
- Total tumor mass (TTM) scoring at diagnosis may not be a reliable prognostic indicator for CLL.
- Doubling time of total tumor mass (DT TTM) warrants further investigation as a prognostic marker in CLL.
- A large-scale, cooperative study is necessary to establish robust prognostic criteria for CLL.